Table 2. League table presenting the treatment estimates and 95% confidence intervals of BWLT, ALT, and NLT for post-TBI sleepiness, sleep disturbance, depression and fatiguea,b - a random-effect model network meta-analysis estimates (lower triangle) and direct estimates (upper triangle)c.
| (A) SMDs for the reduction of sleepiness (95% CIs) | (B) SMDs for the reduction of sleep disturbance (95% CIs) | ||||
| BWLT | -0.47 (-2.26 to 1.31) | -1.52 (-2.98 to -0.07) | BWLT | -0.15 (-1.42 to 1.11) | -0.98 (-2.32 to 0.37) |
| -0.80 (-2.50 to 0.90) | NLT | 0.57 (-1.95 to 3.08) | -0.40 (-1.62 to 0.83) | ALT | 0.20 (-1.64 to 2.04) |
| -1.36 (-2.78 to 0.06) | -0.56 (-2.49 to 1.38) | ALT | -0.88 (-2.18 to 0.41) | -0.49 (-1.99 to 1.02) | NLT |
| (C) SMDs for the reduction of depression (95% CIs) | (D) SMDs for the reduction of Fatigue (95% CIs) | ||||
| BWLT | -0.55 (-1.09 to -0.01) | -0.77 (-1.42 to -0.12) | BWLT | -1.00 (-1.95 to -0.06) | -1.09 (-1.76 to -0.41) |
| -0.57 (-1.10 to -0.04) | ALT | -0.26 (-1.14 to 0.62) | -1.00 (-1.86 to -0.14) | ALT | -0.09 (-0.97 to 0.79) |
| -0.81 (-1.43 to -0.20) | -0.24 (-0.94 to 0.45) | NLT | -1.09 (-1.76 to -0.41) | -0.09 (-0.91 to 0.74) | NLT |
a SMDs less than 0 indicate the superiority of the light therapy defined in the column over the other light therapy defined in the row.
b Bold figures indicate significant differences between types of light therapy.
c Treatment are reported in order of ranking of efficacy. Comparison treatment should be read from left to right, and their standardized mean difference (SMD) in the cell in common between the column-defining light therapy and the row-defining light therapy.